Infiuss Health
AI platform that creates digital patient twins to simulate clinical trial outcomes and support precision medicine
infiuss.com ↗📍 Buffalo, New York
Verified Data
“Estimated <50,000 monthly visits (not publicly listed on SimilarWeb)”
“Clinical Trial Platform (Data points for thousands of patients across Africa)”
“Raised $3M within months of formation; expansion from Africa to global pharma markets”
Company Profile
Contact
@infiussStrategic Analysis
Strategy
Building a two-sided marketplace for decentralized clinical research, focusing on diversifying patient populations particularly in Africa. Leveraging AI and digital patient twins to improve trial design and outcomes while expanding from African markets to global pharmaceutical companies.
Tactics
Custom enterprise pricing model with demo-driven sales process. Heavy content marketing through insights and educational content about AI in clinical trials. Targeting global pharma companies and CROs while maintaining operational presence in both US and Africa.
Competitive Positioning
Differentiates on patient diversity and decentralized trial capabilities, particularly strong in African markets. Positions as an AI-native platform using digital patient twins versus traditional clinical trial management systems.
Marketing Approach
Content-led growth through educational insights about AI clinical trial design and digital patient twins. LinkedIn presence for B2B outreach to life science professionals. Demo-driven sales process for enterprise customers.
Notable
Operations in both US and Africa, focus on patient diversity in clinical trials
Tech Stack
VueJS
SlackRecent News
Related AI Healthcare Companies
Discovery Sources
Signals
“Estimated <50,000 monthly visits (not publicly listed on SimilarWeb)”
“Raised $3M within months of formation; expansion from Africa to global pharma markets”
“Clinical Trial Platform (Data points for thousands of patients across Africa)”